The quadrivalent HPV vaccine, developed by multinational pharmaceutical company Merck, was approved on Jan 8 for males on the Chinese mainland. The vaccine targets HPV types 6, 11, 16 and 18. The ...

The Human Papillomavirus commonly known as HPV impacts men as much as it impacts women but topics such as HPV in men and penile cancer are rarely discussed.

US pharmaceutical company Merck & Co said on Wednesday that its four-valent human papillomavirus vaccine has been approved for men aged 9 to 26 by China's top drug regulator.

U.S. drugmaker Merck & Co said on Wednesday its human papillomavirus (HPV) vaccine for men has been approved by China's medical products administration, providing a much-needed boost to the company in ...

Cervical cancer is often highly treatable, with a five-year relative survival rate of 91% for localised, early-stage disease.

HPV can cause a variety of cancers, including cervical. New mortality data for women under 25 point to the success of the HPV vaccine.

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Discover how the HPV vaccine is changing cancer prevention for both men and women with remarkable protection rates.

The human papillomavirus (HPV) is the most common sexually transmitted infection, and most people will have exposure at some ...

The vaccine is most effective when administered before any exposure to HPV. Here we debunk some of the most common myths ...

Human papillomavirus (HPV) is necessary for the development of cervical carcinoma, and incorporation of molecular testing for HPV in screening and patient management has been proposed. Sufficient ...

Island Health nurses are making their rounds in schools across Vancouver Island to administer the human papillomavirus (HPV) ...